Skip to content

Extracranial Carotid & Intracranial Arterial Stenosis in Ischemic Stroke

Association Between Extracranial Carotid & Intracranial Arterial Stenosis in Ischemic Stroke Patients: Predictors & Outcome

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04162587
Enrollment
120
Registered
2019-11-14
Start date
2019-05-01
Completion date
2020-08-01
Last updated
2019-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Stroke, Carotid Stenosis

Keywords

Ischemic Stroke, carotid stenosis

Brief summary

The aim of the work is to; elucidate how the presence of carotid stenosis influence the pattern of stroke and also how it interact with other risk factors for stroke. Also identify predictors of intracranial stenosis and outcome in patients with carotid stenosis with or without intracranial stenosis.

Detailed description

Patients: Ischemic stroke patients admitted to Neurology department in Mansoura University hospital (MUH) will be studied The patients will be grouped as follow: 1. Patients with significant carotid stenosis without intracranial stenosis. 2. Patients with carotid and intracranial stenosis. 3. Patients with lone intracranial stenosis. 4. patients with no significant carotid or intracranial stenosis. Methods: Studied patients will undergo the following: * Clinical assessment with NIH scale with is a systematic assessment tool that provides a quantitative measure of stroke-related neurologic deficit, Modified Rankin Scale, Arabic version of Montereal Coginitive Assessment and Arabic version of Beck's Depression Inventory at presentation and after 6 months. * carotid duplex+/- MRA neck and brain MRA+/-CT angio on carotid and brain (at 0day) and 6m after. * MRI brain with diffusion to detect asymptomatic stroke at 0 day and 6 months later. * DSA (digital subtraction angiography) in some cases to confirm diagnosis. * Laboratory investigations: complete blood count, liver function and renal function tests, random blood sugar, lipid profile. All patients will be treated with acetyle-salicylic acid(150/day) +/-clopidogrel (75mg /day) +/- statins, plus modification of risk factors.

Interventions

OTHERCarotid duplex+/- MRA neck

Carotid duplex and or MRA neck

OTHERbrain MRA+/-CT angio on carotid and brain

brain MRA and or CT angiography on carotid and brain

MRI brain with diffusion to detect asymptomatic stroke

OTHERDSA (digital subtraction angiography)

DSA (digital subtraction angiography) in some cases to confirm diagnosis.

Sponsors

Mansoura University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Carotid TIA (transient ischemic attack) it should, however, be focal and usually motor-sensory to implicate the carotid artery system or ischemic stroke involving carotid territory. * Asymptomatic patients with carotid stenosis or anterior circulation stenosis discovered accidentally during investigations for further risk factors.

Exclusion criteria

* Major functional impairment (Modified Rankin Scale \>/= 3) * Significant cognitive impairment. * Contraindication to acetylsalicylic or dual antiplatelet. * Renal dysfunction precluding safe contrast medium administration. * pregnancy or refusal. * Intracranial aneurysm or AVM. * Intra cerebral hemorrhage or hemorrhagic infarction.

Design outcomes

Primary

MeasureTime frameDescription
National Institutes of Health Stroke Scale24 hoursThe National Institutes of Health Stroke Scale is a tool used by healthcare providers to objectively quantify the impairment caused by a stroke. The NIHSS is composed of 11 items, each of which scores a specific ability between a 0 and 4. For each item, a score of 0 typically indicates normal function in that specific ability, while a higher score is indicative of some level of impairment. The individual scores from each item are summed in order to calculate a patient's total NIHSS score. The maximum possible score is 42, with the minimum score being a 0. The higher score indicate poor outcome.

Secondary

MeasureTime frameDescription
The modified Rankin Scale24 hoursThe modified Rankin Scale is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. It has become the most widely used clinical outcome measure for stroke clinical trials. The higher score indicate poor outcome.
Beck's Depression Inventory24hoursThe Beck Depression Inventory, created by Aaron T. Beck, is a 21-question multiple-choice self-report inventory, one of the most widely used psychometric tests for measuring the severity of depression.

Countries

Egypt

Contacts

Primary ContactEsmael M Ahmed, MD
deltaneuro@yahoo.com00201000372787

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026